• 1
    Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299.
  • 2
    Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010; 33: 23552359.
  • 3
    Hopper I, Billah B, Skiba M, Krum H. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 2011; 18: 813823.
  • 4
    International Diabetes Federation. Diabetes Atlas, 5th edn. Brussels: International Diabetes Federation, 2011.
  • 5
    Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 11831197.
  • 6
    World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
  • 7
    Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 31603167.
  • 8
    International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 13271334.
  • 9
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62S69.
  • 10
    Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and prediabetes with proposed A1c-based diagnostic criteria. Diabetes Care 2010; 33: 21842189.
  • 11
    James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC et al. Implications of alternative definitions of prediabetes for prevalence in U.S. Adults. Diabetes Care 2011; 34: 387391.
  • 12
    Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H et al. HbA1c 5.7–6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011; 378: 147155.
  • 13
    Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011; 34: 8489.
  • 14
    Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010; 47: 231236.
  • 15
    Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009; 32: 644646.
  • 16
    Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes. Diabet Med 2008; 25: 11571163.
  • 17
    Schottker B, Raum E, Rothenbacher D, Muller H, Brenner H. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 2011; 26: 779787.
  • 18
    Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T et al. What has made the population of Japan healthy? Lancet 2011; 378: 10941105.
  • 19
    The Committee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Jpn Diabetes Soc 2010; 53: 450467.
  • 20
    Eide GE, Heuch I. Average attributable fractions: a coherent theory for apportioning excess risk to individual risk factors and subpopulations. Biom J 2006; 48: 820837.
  • 21
    Hill GB. The value of the population attributable risk percentage. Am J Public Health 1996; 86: 1483.
  • 22
    Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 1519.
  • 23
    Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010; 33: 14841490.
  • 24
    Cheng P, Neugaard B, Foulis P, Conlin PR. Hemoglobin A1c as a predictor of incident diabetes. Diabetes Care 2011; 34: 610615.
  • 25
    Bonora E, Kiechl S, Mayr A, Zoppini G, Targher G, Bonadonna RC et al. High-normal HbA1c is a strong predictor of Type 2 Diabetes in the general population. Diabetes Care 2011; 34: 10381040.
  • 26
    Ferrannini E, Massari M, Nannipieri M, Natali A, Ridaura RL, Gonzales-Villalpando C. Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study. Diabetologia 2009; 52: 818824.
  • 27
    Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 21292140.
  • 28
    Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997–2008. Diabetes Care 2011; 34: 353357.
  • 29
    Mukai N, Doi Y, Ninomiya T, Hata J, Yonemoto K, Iwase M et al. Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 2009; 32: 22882293.
  • 30
    Saito I, Kokubo Y, Yamagishi K, Iso H, Inoue M, Tsugane S. Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis 2011; 216: 187191.